The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder.
Francis M DijkstraAurora Jae van de LooSmedra AbdulahadElse R BosmaMitch HartogHendrikje HulsDianne C KuijperEsther de VriesBhavna SolankiJaskaran SinghLeah AluisioPeter ZannikosFrederik E StuurmanGabriël E JacobsJoris C VersterPublished in: Journal of psychopharmacology (Oxford, England) (2022)
In this study, esketamine did not impair on-road driving performance the next morning following a single dose, or on same day after repeated administration.